Treace Medical Concepts, Inc. TMCI Accrued Commissions
Accrued Commissions at other companies
Other financials
Where this comes from
Reported directly by Treace Medical Concepts, Inc. in its filing.
Tagged under the XBRL concept tmci:AccruedCommissions.
The official record: Treace Medical Concepts, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Treace Medical Concepts, Inc.'s accrued commissions.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Treace Medical Concepts, Inc.'s accrued commissions?
- Treace Medical Concepts, Inc. (TMCI) reported accrued commissions of $6.76M in Q1 2026.
- How has Treace Medical Concepts, Inc.'s accrued commissions changed year-over-year?
- Treace Medical Concepts, Inc.'s accrued commissions increased by 3.5% year-over-year, from $6.53M to $6.76M.
- What is the long-term trend for Treace Medical Concepts, Inc.'s accrued commissions?
- Over 5 years (2020 to 2025), Treace Medical Concepts, Inc.'s accrued commissions has grown at a 21.7% compound annual growth rate (CAGR), from $3.51M to $9.37M.
- What does accrued commissions mean?
- This represents the total amount of sales commissions earned by employees or third-party sales representatives that have been recognized as an expense but have not yet been paid out in cash. It serves as a short-term liability reflecting the company's obligation to compensate its sales force for completed transactions. Monitoring this balance helps investors understand the timing of sales incentive payouts and potential cash flow impacts in the upcoming period.